Bystander protein protects potential vaccine-targeting ligands against intestinal proteolysis

Journal of Controlled Release

Volumn 137, Issue 2, 2009, Pages 98-103

  Reuter, Fabian ^a   Bade, Steffen ^a   Hirst, Timothy R ^b   Frey, Andreas ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

^b Australian National University   (Australia)

Author keywords

Cholera toxin B subunit (CTB); Degradation resistance; E. coli heat labile enterotoxin B subunit (LTB); Gastro intestinal tract; Ulex europaeus agglutinin I (UEA I)

Indexed keywords

CHOLERA TOXIN B SUBUNIT (CTB); DEGRADATION RESISTANCE; E. COLI HEAT-LABILE ENTEROTOXIN B SUBUNIT (LTB); GASTRO-INTESTINAL TRACT; ULEX EUROPAEUS AGGLUTININ I (UEA I);

DEGRADATION; ENZYME INHIBITION; ESCHERICHIA COLI; HEAT RESISTANCE; SUBSTRATES; TOXIC MATERIALS; VACCINES;

LIGANDS;

ALBUMIN; CHOLERA TOXIN B SUBUNIT; CHYMOTRYPSIN; ESCHERICHIA COLI ENTEROTOXIN; PANCREATIC ELASTASE; PROTEINASE; TRYPSIN; ULEX EUROPAEUS AGGLUTININ; VACCINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME SUBSTRATE; FEMALE; IMMUNIZATION; INTESTINE FLUID; INTESTINE MUCOSA; LYMPHOID TISSUE; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DETERMINATION;

ANIMALS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CHOLERA TOXIN; ENTEROTOXINS; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; FEMALE; GASTROINTESTINAL CONTENTS; INTESTINE, SMALL; MICE; MICE, INBRED BALB C; MODELS, BIOLOGICAL; PEPTIDE HYDROLASES; PLANT LECTINS; PROTEASE INHIBITORS; RECOMBINANT PROTEINS; ULEX; VIBRIO CHOLERAE;

EID: 67349242274     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2009.03.015     Document Type: Article

References (26)

1. Holmgren J., and Czerkinsky C. Mucosal immunity and vaccines. Nat. Med. 11 4 (2005) 45-53
2. Lue C., van den Wall Bake A.W.L., Prince S.J., Julian B.A., Tseng M.-L., Radl J., Elson C.O., and Mestecky J. Intraperitoneal immunization of human subjects with tetanus toxoid induces specific antibody-secreting cells in the peritoneal cavity and in the circulation, but fails to elicit a secretory IgA response. Clin. Exp. Immunol. 96 2 (1994) 356-363
3. Neutra M.R., Frey A., and Kraehenbuhl J.-P. Epithelial M cells: gateways for mucosal infection and immunization. Cell 86 3 (1996) 345-248
4. Frey A., and Neutra M.R. Targeting of mucosal vaccines to Peyer's patch M cells. Behring-Inst.-Mitt. 98 (1997) 376-378
5. Giannasca P.J., Giannasca K.T., Falk P., Gordon J.I., and Neutra M.R. Regional differences in glycoconjugates of intestinal M cells in mice: potential targets for mucosal vaccines. Am. J. Physiol. 267 6 Pt 1 (1994) G1108-G1121
6. Clark M.A., Jepson M.A., Simmons N.L., and Hirst B.H. Selective binding and transcytosis of Ulex europaeus 1 lectin by mouse Peyer's patch M-cells in vivo. Cell Tissue Res. 282 3 (1995) 455-461
7. Schengrund C.L., and Ringler N.J. Binding of Vibrio cholera toxin and the heat-labile enterotoxin of Escherichia coli to GM1, derivatives of GM1, and nonlipid oligosaccharide polyvalent ligands. J. Biol. Chem. 264 22 (1989) 13233-13237
8. Fishman P.H., Pacuszka T., and Orlandi P.A. Gangliosides as receptors for bacterial enterotoxins. Adv. Lipid Res. 25 (1993) 165-187
9. Frey A., Giannasca K.T., Weltzin R., Giannasca P.J., Reggio H., Lencer W.I., and Neutra M.R. Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting. J. Exp. Med. 184 3 (1996) 1045-1059
10. Frey A., Meckelein B., and Schmidt M.A. Grafting protein ligand monolayers onto the surface of microparticles for probing the accessibility of cell surface receptors. Bioconjugate Chem. 10 4 (1999) 562-571
11. Olivier V., Meisen I., Meckelein B., Hirst T.R., Peter-Katalinic J., Schmidt M.A., and Frey A. Influence of targeting ligand flexibility on receptor binding of particulate drug delivery systems. Bioconjugate Chem. 14 6 (2003) 1203-1208
12. Woodley J.F. Enzymatic barriers for GI peptide and protein delivery. Crit. Rev. Ther. Drug Carr. Syst. 11 2-3 (1994) 61-95
13. Ruddock L.W., Ruston S.P., Kelly S.M., Price N.C., Freedman R.B., and Hirst T.R. Kinetics of acid-mediated disassembly of the B subunit pentamer of Escherichia coli heat-labile enterotoxin. Molecular basis of pH stability. J. Biol. Chem. 270 50 (1995) 29953-29958
14. Haneberg B., Kendall D., Amerongen H.M., Apter F.M., Kraehenbuhl J.P., and Neutra M.R. Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces. Infect. Immun. 62 1 (1994) 15-23
15. Laine J., Beattie M., and LeBel D. Simultaneous kinetic determinations of lipase, chymotrypsin, trypsin, elastase, and amylase on the same microtiter plate. Pancreas 8 3 (1993) 383-386
16. Lockwood J.S., and Randall H.T. The place of electrolyte studies in surgical patients. Bull. N. Y. Acad. Med. 25 4 (1949) 228-239
17. Hatakeyama T., Kohzaki H., and Yamasaki N. A microassay for proteases using succinylcasein as a substrate. Anal. Biochem. 204 1 (1992) 181-184
18. Amin T., and Hirst T.R. Purification of the B-subunit oligomer of Escherichia coli heat-labile enterotoxin by heterologous expression and secretion in a marine Vibrio. Protein Expr. Purif. 5 2 (1994) 198-204
19. Richards C.M., Aman A.T., Hirst T.R., Hill T.J., and Williams N.A. Protective mucosal immunity to ocular herpes simplex virus type 1 infection in mice by using Escherichia coli heat-labile enterotoxin B subunit as an adjuvant. J. Virol. 75 4 (2001) 1664-1671
20. Bade S., Baier M., Boetel T., and Frey A. Intranasal immunization of Balb/c mice against prion protein attenuates orally acquired transmissible spongiform encephalopathy. Vaccine 24 9 (2006) 1242-1253
21. Cobelens P.M., Heijnen C.J., Nieuwenhuis E.E., Kramer P.P., van der Zee R., van Eden W., and Kavelaars A. Treatment of adjuvant-induced arthritis by oral administration of mycobacterial Hsp65 during disease. Arthritis Rheum. 43 12 (2000) 2694-2702
22. Gorris H.H., Bade S., Röckendorf N., Albers E., Schmidt M.A., Fránek M., and Frey A. Rapid profiling of peptide stability in proteolytic environments. Anal. Chem. 81 4 (2009) 1580-1586
23. Schwarz R., Kaspar A., Seelig J., and Kunnecke B. Gastrointestinal transit times in mice and humans measured with 27Al and 19F nuclear magnetic resonance. Magn. Reson. Med. 48 2 (2002) 255-261
24. Anderle P., Langguth P., Rubas W., and Merkle H.P. In vitro assessment of intestinal IGF-I stability. J. Pharm. Sci. 91 1 (2002) 290-300
25. Ohtani S., Shirasu K., Ogawara K., Higaki K., and Kimura T. Evaluation of inhibitory activity of casein on proteases in rat intestine. Pharm. Res. 20 4 (2003) 611-617
26. Fan E., Merritt E.A., Verlinde C.L., and Hol W.G. AB(5) toxins: structures and inhibitor design. Curr. Opin. Struct. Biol. 10 6 (2000) 680-686